Delaware (State or Other Jurisdiction Of Incorporation) |
1-815 (Commission File Number) |
51-0014090 (I.R.S. Employer Identification No.) |
2
E. I. DU PONT DE NEMOURS AND COMPANY (Registrant) |
||||
/s/ Barry J. Niziolek | ||||
Barry J. Niziolek | ||||
Vice President and Controller | ||||
3
APRIL 21, 2009 WILMINGTON, Del. |
Media Contact: | Anthony Farina 302-773-4418 anthony.r.farina@usa.dupont.com |
||
Investor Contact: | 302-774-4994 |
| DuPonts first quarter 2009 earnings were $.54 per share, in-line with guidance. Results reflect earnings from Agriculture & Nutrition and pharmaceuticals, strong companywide pricing and cost discipline, partly offset by the impact of a severe decline in global industrial demand. | ||
| The Agriculture & Nutrition segment performance was strong, with sales growth of 6 percent and earnings growth of 8 percent despite significant currency headwinds. Performance was driven by higher North American volumes and significant seed pricing gains. | ||
| DuPont increased its 2009 fixed cost reduction goal to $1 billion and reduced planned capital expenditures an additional $200 million, to $1.4 billion. | ||
| The company revised its full-year 2009 earnings outlook to a range of $1.70 to $2.10 per share, with the expectation of difficult market conditions continuing with the exception of global agriculture markets. | ||
| DuPont declared a second quarter dividend of $.41 per share, unchanged from the first quarter. This is the companys 419th consecutive dividend. |
2
Three Months Ended | ||||||||||||||||||||||||
March 31, 2009 | Percentage Change Due to: | |||||||||||||||||||||||
Local | ||||||||||||||||||||||||
% | Currency | Currency | Portfolio/ | |||||||||||||||||||||
(dollars in billions) | $ | Change | Price | Effect | Volume | Other | ||||||||||||||||||
U.S. |
$ | 3.1 | (9 | ) | 6 | | (14 | ) | (1 | ) | ||||||||||||||
Europe |
2.1 | (28 | ) | 3 | (11 | ) | (20 | ) | | |||||||||||||||
Asia Pacific |
0.9 | (28 | ) | 5 | (1 | ) | (31 | ) | (1 | ) | ||||||||||||||
Canada & Lat. America |
0.8 | (22 | ) | 9 | (11 | ) | (19 | ) | (1 | ) | ||||||||||||||
Total Consolidated Sales |
$ | 6.9 | (20 | ) | 5 | (5 | ) | (19 | ) | (1 | ) |
1Q | ||||
EPS 2008 |
$ | 1.31 | ||
Local prices |
.37 | |||
Variable costs* |
(.16 | ) | ||
Volume |
(.62 | ) | ||
Low Capacity Utilization** |
(.18 | ) | ||
Fixed costs * |
.05 | |||
Currency |
(.18 | ) | ||
Exchange loss |
(.02 | ) | ||
Tax |
.02 | |||
Other*** |
(.05 | ) | ||
EPS 2009 |
$ | .54 | ||
* | Excluding volume & currency impact. | |
** | Fixed manufacturing cost, normally reflected in inventory, expensed as a result of low production volumes. | |
*** | Includes interest expense, income from pharmaceuticals and equity affiliates, and the impact of portfolio changes. |
3
Three Months Ended March 31, 2009 |
Percentage
Change Due to: |
|||||||||||||||||||
SEGMENT SALES* | USD | Portfolio | ||||||||||||||||||
(Dollars in billions) | $ | % Change | Price | Volume | and Other | |||||||||||||||
Agriculture & Nutrition |
$ | 3.1 | 6 | 5 | 1 | | ||||||||||||||
Coatings & Color Technologies |
1.2 | (30 | ) | (1 | ) | (29 | ) | | ||||||||||||
Electronic & Communication Technologies |
0.7 | (32 | ) | (1 | ) | (31 | ) | | ||||||||||||
Performance Materials |
0.9 | (45 | ) | (3 | ) | (39 | ) | (3 | ) | |||||||||||
Safety & Protection |
1.0 | (24 | ) | (5 | ) | (18 | ) | (1 | ) |
* | Segment sales include transfers |
Three Months Ended | ||||||||
Mar 31, 2009 | ||||||||
(Dollars in millions) | 2009 | 2008 | ||||||
Agriculture & Nutrition |
$ | 852 | $ | 786 | ||||
Coatings & Color Technologies |
(19 | ) | 190 | |||||
Electronic & Communication Technologies |
(54 | ) | 175 | |||||
Performance Materials |
(146 | ) | 219 | |||||
Safety & Protection |
72 | 272 | ||||||
Total Growth Platforms |
705 | 1,642 | ||||||
Pharmaceuticals |
252 | 235 | ||||||
Other |
(44 | ) | (26 | ) | ||||
Total Segments |
$ | 913 | $ | 1,851 |
4
| Sales of $3.1 billion were up 6 percent reflecting production agriculture price increases and North America and Europe seed volume gains, partly offset by currency. |
| PTOI was $852 million, up 8 percent, driven by higher sales, partly offset by significant unfavorable currency impact and increased input costs. |
| Sales of $1.2 billion were down 30 percent primarily reflecting broad-based volume declines across all regions and businesses. |
| The pre-tax loss of $19 million reflects lower sales volumes and unfavorable currency impact partly offset by fixed cost reductions and higher local prices. |
| Sales of $696 million were down 32 percent reflecting 31 percent lower volumes and 1 percent lower selling prices. Lower volumes reflect significant de-stocking in supply chains for many electronic materials and general industrial markets. |
| The pre-tax loss of $54 million reflects the depressed sales volumes and higher input costs, partly offset by fixed cost reductions. |
| Sales of $942 million were down 45 percent reflecting declines in major markets in all regions, precipitated by de-stocking and weak final demand, particularly in motor vehicle and general industrial end markets. |
| The pre-tax loss of $146 million reflects lower volume and higher raw material costs, partly offset by reductions in fixed costs. |
| Sales of $1.0 billion were down 24 percent reflecting an 18 percent volume decline and 5 percent lower selling prices. Volumes were down in all product lines, most significantly in North American and European motor vehicle, construction and general industrial markets. |
| PTOI of $72 million principally reflects the impact of lower sales volumes. |
5
| The company is increasing its 2009 fixed cost reduction goal from $730 million to $1 billion. In December 2008, DuPont initiated $600 million in fixed cost reduction projects and a restructuring program with $130 million in restructuring benefits for 2009. The company has now identified an additional $200 million in cost reduction actions, including reducing additional contractor positions and work schedule reductions. DuPont is also developing plans for additional restructuring actions, expected to be finalized and approved in the second quarter 2009, with a targeted $70 million pre-tax savings and positive cash flow benefit in 2009. This is in addition to restructuring plans announced in December 2008. | |
| The company is reducing 2009 capital expenditures from $1.6 billion to $1.4 billion, 30 percent below 2008 expenditures of $2.0 billion. | |
| Working capital reduction projects are fully underway and expected to deliver a $1 billion improvement over 2008, as previously announced. | |
| Based on the above, the full year outlook for free cash flow remains about $2.5 billion. |
6
7
Three Months Ended | ||||||||
March 31, | ||||||||
2009 | 2008 | |||||||
Net sales |
$ | 6,871 | $ | 8,575 | ||||
Other income, net |
399 | 195 | ||||||
Total |
7,270 | 8,770 | ||||||
Cost of goods sold and other operating charges |
5,185 | 5,956 | ||||||
Selling, general and administrative expenses |
907 | 934 | ||||||
Research and development expense |
323 | 330 | ||||||
Interest expense |
106 | 80 | ||||||
Total |
6,521 | 7,300 | ||||||
Income before income taxes |
749 | 1,470 | ||||||
Provision for income taxes |
260 | 273 | ||||||
Net income |
489 | 1,197 | ||||||
Less: Net income attributable to noncontrolling interests |
1 | 6 | ||||||
Net income attributable to DuPont |
$ | 488 | $ | 1,191 | ||||
Basic earnings per share of common stock |
$ | 0.54 | $ | 1.32 | ||||
Diluted earnings per share of common stock |
$ | 0.54 | $ | 1.31 | ||||
Dividends per share of common stock |
$ | 0.41 | $ | 0.41 | ||||
Average number of shares outstanding used in earnings per
share (EPS) calculation: |
||||||||
Basic |
903,893,000 | 900,646,000 | ||||||
Diluted |
905,665,000 | 906,193,000 |
8
March 31, | December 31, | |||||||
2009 | 2008 | |||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | 2,386 | $ | 3,645 | ||||
Marketable securities |
21 | 59 | ||||||
Accounts and notes receivable, net |
6,423 | 5,140 | ||||||
Inventories |
4,615 | 5,681 | ||||||
Prepaid expenses |
200 | 143 | ||||||
Income taxes |
570 | 643 | ||||||
Total current assets |
14,215 | 15,311 | ||||||
Property, plant and equipment, net of accumulated depreciation
(March 31, 2009 $17,117; December 31, 2008 $16,800) |
11,164 | 11,154 | ||||||
Goodwill |
2,128 | 2,135 | ||||||
Other intangible assets |
2,612 | 2,710 | ||||||
Investment in affiliates |
877 | 844 | ||||||
Other assets |
3,892 | 4,055 | ||||||
Total |
$ | 34,888 | $ | 36,209 | ||||
Liabilities and Stockholders Equity |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ | 2,300 | $ | 3,128 | ||||
Short-term borrowings and capital lease obligations |
1,569 | 2,012 | ||||||
Income taxes |
155 | 110 | ||||||
Other accrued liabilities |
3,578 | 4,460 | ||||||
Total current liabilities |
7,602 | 9,710 | ||||||
Long-term borrowings and capital lease obligations |
8,490 | 7,638 | ||||||
Other liabilities |
11,011 | 11,169 | ||||||
Deferred income taxes |
142 | 140 | ||||||
Total liabilities |
27,245 | 28,657 | ||||||
Commitments and contingent liabilities |
||||||||
Stockholders equity |
||||||||
Preferred stock |
237 | 237 | ||||||
Common stock, $0.30 par value; 1,800,000,000 shares authorized;
issued at March 31, 2009 990,624,000; December 31, 2008
989,415,000 |
297 | 297 | ||||||
Additional paid-in capital |
8,396 | 8,380 | ||||||
Reinvested earnings |
10,569 | 10,456 | ||||||
Accumulated other comprehensive loss |
(5,558 | ) | (5,518 | ) | ||||
Common stock held in treasury, at cost
(87,041,000 shares at March 31,
2009
and December 31, 2008) |
(6,727 | ) | (6,727 | ) | ||||
Total DuPont stockholders equity |
7,214 | 7,125 | ||||||
Noncontrolling interests |
429 | 427 | ||||||
Total stockholders equity |
7,643 | 7,552 | ||||||
Total |
$ | 34,888 | $ | 36,209 | ||||
9
Three Months Ended | ||||||||
March 31, | ||||||||
2009 | 2008 | |||||||
Cash used for operating activities |
$ | (832 | ) | $ | (951 | ) | ||
Investing activities |
||||||||
Purchases of property, plant and equipment |
(358 | ) | (410 | ) | ||||
Investments in affiliates |
(8 | ) | (3 | ) | ||||
Other investing activities net |
(27 | ) | (107 | ) | ||||
Cash used for investing activities |
(393 | ) | (520 | ) | ||||
Financing activities |
||||||||
Dividends paid to stockholders |
(375 | ) | (372 | ) | ||||
Net increase in borrowings |
433 | 1,611 | ||||||
Other financing activities net |
(38 | ) | 23 | |||||
Cash provided by financing activities |
20 | 1,262 | ||||||
Effect of exchange rate changes on cash |
(54 | ) | (2 | ) | ||||
Decrease in cash and cash equivalents |
(1,259 | ) | (211 | ) | ||||
Cash and cash equivalents at beginning of period |
3,645 | 1,305 | ||||||
Cash and cash equivalents at end of period |
$ | 2,386 | $ | 1,094 | ||||
10
11
Three Months Ended | ||||||||
March 31, | ||||||||
SEGMENT SALES (1) | 2009 | 2008 | ||||||
Agriculture & Nutrition |
$ | 3,062 | $ | 2,883 | ||||
Coatings & Color Technologies |
1,156 | 1,645 | ||||||
Electronic & Communication Technologies |
696 | 1,026 | ||||||
Performance Materials |
942 | 1,713 | ||||||
Safety & Protection |
1,033 | 1,365 | ||||||
Other |
28 | 40 | ||||||
Total Segment sales |
$ | 6,917 | $ | 8,672 | ||||
Elimination of transfers |
(46 | ) | (97 | ) | ||||
Consolidated net sales |
$ | 6,871 | $ | 8,575 | ||||
Three Months Ended | ||||||||
March 31, | ||||||||
PRETAX OPERATING INCOME/(LOSS) (PTOI) | 2009 | 2008 | ||||||
Agriculture & Nutrition |
$ | 852 | $ | 786 | ||||
Coatings & Color Technologies |
(19 | ) | 190 | |||||
Electronic & Communication Technologies |
(54 | ) | 175 | |||||
Performance Materials |
(146 | ) | 219 | |||||
Safety & Protection |
72 | 272 | ||||||
Total Growth Platforms |
705 | 1,642 | ||||||
Pharmaceuticals |
252 | 235 | ||||||
Other |
(44 | ) | (26 | ) | ||||
Total Segment PTOI |
$ | 913 | $ | 1,851 | ||||
Net exchange gains (losses) (2) |
70 | (155 | ) | |||||
Corporate expenses & net interest |
(234 | ) | (226 | ) | ||||
Income before income taxes |
$ | 749 | $ | 1,470 | ||||
(1) | Sales for the reporting segments include transfers. | |
(2) | Net after-tax exchange activity for the three months ended March 31, 2009 and 2008 were losses of $33 and $14, respectively. Gains and losses resulting from the companys hedging program are largely offset by associated tax effects. See Schedule D for additional information. |
12
Three Months Ended | ||||||||
March 31, | ||||||||
2009 | 2008 | |||||||
Income before income taxes |
$ | 749 | $ | 1,470 | ||||
Less: Net income attributable to noncontrolling interests |
1 | 6 | ||||||
Add: Interest expense |
106 | 80 | ||||||
Adjusted EBIT |
854 | 1,544 | ||||||
Add: Depreciation and amortization |
399 | 380 | ||||||
Adjusted EBITDA |
$ | 1,253 | $ | 1,924 | ||||
Three Months Ended | ||||||||
March 31, | ||||||||
2009 | 2008 | |||||||
Total charges and expenses consolidated income statements |
$ | 6,521 | $ | 7,300 | ||||
Remove: |
||||||||
Interest expense |
(106 | ) | (80 | ) | ||||
Variable costs (1) |
(3,434 | ) | (4,140 | ) | ||||
Fixed costs |
$ | 2,981 | $ | 3,080 | ||||
Consolidated net sales |
$ | 6,871 | $ | 8,575 | ||||
Fixed costs as a percent of consolidated net sales |
43.4 | % | 35.9 | % |
(1) | Includes variable manufacturing costs, freight, commissions and other selling expenses which vary with the volume of sales. |
Three Months Ended | ||||||||
March 31, | ||||||||
2009 | 2008 | |||||||
Cash used by operating activities |
$ | (832 | ) | $ | (951 | ) | ||
Less: Purchases of property, plant and equipment |
358 | 410 | ||||||
Free cash flow |
$ | (1,190 | ) | $ | (1,361 | ) | ||
13
Three Months Ended March 31, |
||||||||
2009 | 2008 | |||||||
Subsidiary/Affiliate Monetary Position Gain/(Loss) |
||||||||
Pretax exchange gains (losses) (includes equity affiliates) |
$ | (125 | ) | $ | 150 | |||
Local tax benefits (expenses) |
(32 | ) | 34 | |||||
Net after-tax impact from subsidiary exchange gains (losses) |
$ | (157 | ) | $ | 184 | |||
Hedging Program Gain/(Loss) |
||||||||
Pretax exchange gains (losses) |
$ | 195 | $ | (305 | ) | |||
Tax benefits (expenses) |
(71 | ) | 107 | |||||
Net after-tax impact from hedging program exchange gains (losses) |
$ | 124 | $ | (198 | ) | |||
Total Exchange Gain/(Loss) |
||||||||
Pretax exchange gains (losses) |
$ | 70 | $ | (155 | ) | |||
Tax benefits (expenses) |
(103 | ) | 141 | |||||
Net after-tax exchange losses |
$ | (33 | ) | $ | (14 | ) | ||
Three Months Ended March 31, |
||||||||
2009 | 2008 | |||||||
Income before income taxes |
$ | 749 | $ | 1,470 | ||||
Less: Net exchange gains (losses) |
70 | (155 | ) | |||||
Income before income taxes and exchange gains/losses |
$ | 679 | $ | 1,625 | ||||
Provision for income taxes |
$ | 260 | $ | 273 | ||||
Tax benefits (expenses) on exchange gains/losses |
(103 | ) | 141 | |||||
Provision for income taxes, excluding taxes on exchange gains/losses |
$ | 157 | $ | 414 | ||||
Effective income tax rate |
34.7 | % | 18.6 | % | ||||
Exchange gains/losses effect |
-11.6 | % | 6.9 | % | ||||
Base income tax rate |
23.1 | % | 25.5 | % | ||||
14
Year Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Outlook | Actual | |||||||
Earnings per share excluding
significant items |
$ | 1.70 to $2.10 | $ | 2.78 | ||||
Significant items included in EPS: |
||||||||
Hurricane charge |
| (0.16 | ) | |||||
Restructuring charge |
| (0.42 | ) | |||||
Net charge for significant items |
| (0.58 | ) | |||||
Reported EPS |
$ | 1.70 to $2.10 | $ | 2.20 | ||||